SAN DIEGO, Calif., March 6 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences will present an overview of the Company including indiplon highlights and the Company’s broad development pipeline at SG Cowen & Company’s 26th Annual Healthcare Conference. The live presentation will take place Tuesday, March 7, 2006 at 1:30 p.m. Eastern Time (ET) / 10:30 a.m. Pacific Time (PT) at the Boston Marriott Copley Place Hotel. The presentation will be simultaneously webcast and can be accessed on the Company’s website at http://www.neurocrine.com
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Woodworth or Elizabeth Foster. A replay will become available approximately one hour after the live event concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived until Tuesday, March 21, 2006.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com
Neurocrine Biosciences, Inc.
CONTACT: Claudia Woodworth or Elizabeth Foster, both of NeurocrineBiosciences, Inc., +1-858-617-7600
Web site: http://www.neurocrine.com/
